Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lewis B Kinter

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Handbook of Experimental Pharmacology|June 21, 2015
A Historical View and Vision into the Future of the Field of Safety PharmacologyAlan S Bass, Toshiyasu Hombo, Chieko Kasai, et al.
Toxicology and Applied Pharmacology|October 21, 2017
Perspectives on using a multiplex human kidney safety biomarker panel to detect cisplatin-induced tubular toxicity in male and female Cynomolgus monkeysYafei Chen, J Dale Thurman, Lewis B Kinter, et al.
Integrated Environmental Assessment and Management|June 30, 2009
Using data from drug discovery and development to aid the aquatic environmental risk assessment of human pharmaceuticals: concepts, considerations, and challengesMatthew J Winter, Stewart F Owen, Richard Murray-Smith, et al.
Toxicology Reports|October 1, 2017
A peripherally restricted P2Y<sub>12</sub> receptor antagonist altered rat tumor incidences with no human relevance: Mode of action consistent with dopamine agonismDavid A Brott, Håkan A S Andersson, Jane Stewart, et al.
Bioanalysis|November 19, 2010
Conference Report: DIA/PhRMA workshop on DBS sampling in the pharmaceutical industry: methodology, implementation & best practicesChristopher A Evans, Christopher Bruce, Gary T Emmons, et al.
Aquatic Toxicology (Amsterdam, Netherlands)|June 12, 2009
Uptake of propranolol, a cardiovascular pharmaceutical, from water into fish plasma and its effects on growth and organ biometryStewart F Owen, Duane B Huggett, Thomas H Hutchinson, et al.
Journal of Pharmacological and Toxicological Methods|June 22, 2011
Safety pharmacology in 2010 and beyond: survey of significant events of the past 10 years and a roadmap to the immediate-, intermediate- and long-term future in recognition of the tenth anniversary of the Safety Pharmacology SocietyAlan S Bass, Hugo M Vargas, Jean-Pierre Valentin, et al.
Toxicology|November 20, 2012
Renal biomarker changes associated with hyaline droplet nephropathy in rats are time and potentially compound dependentDavid A Brott, Patricia Bentley, Murali V P Nadella, et al.
Basic & Clinical Pharmacology & Toxicology|June 30, 2012
Inhibition of oestradiol-induced prolactin release in a dual-cannulated ovariectomized rat model by carmoxirole, a peripherally restricted dopamine agonistDavid A Brott, Jennifer L Werkheiser, Pam Campbell, et al.
Environmental Toxicology and Chemistry|September 14, 2010
The value of repeating studies and multiple controls: replicated 28-day growth studies of rainbow trout exposed to clofibric acidStewart F Owen, Duane B Huggett, Thomas H Hutchinson, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Handbook of Experimental Pharmacology|June 21, 2015
A Historical View and Vision into the Future of the Field of Safety PharmacologyAlan S Bass, Toshiyasu Hombo, Chieko Kasai, et al.
Toxicology and Applied Pharmacology|October 21, 2017
Perspectives on using a multiplex human kidney safety biomarker panel to detect cisplatin-induced tubular toxicity in male and female Cynomolgus monkeysYafei Chen, J Dale Thurman, Lewis B Kinter, et al.
Integrated Environmental Assessment and Management|June 30, 2009
Using data from drug discovery and development to aid the aquatic environmental risk assessment of human pharmaceuticals: concepts, considerations, and challengesMatthew J Winter, Stewart F Owen, Richard Murray-Smith, et al.
Toxicology Reports|October 1, 2017
A peripherally restricted P2Y<sub>12</sub> receptor antagonist altered rat tumor incidences with no human relevance: Mode of action consistent with dopamine agonismDavid A Brott, Håkan A S Andersson, Jane Stewart, et al.
Bioanalysis|November 19, 2010
Conference Report: DIA/PhRMA workshop on DBS sampling in the pharmaceutical industry: methodology, implementation & best practicesChristopher A Evans, Christopher Bruce, Gary T Emmons, et al.
Aquatic Toxicology (Amsterdam, Netherlands)|June 12, 2009
Uptake of propranolol, a cardiovascular pharmaceutical, from water into fish plasma and its effects on growth and organ biometryStewart F Owen, Duane B Huggett, Thomas H Hutchinson, et al.
Journal of Pharmacological and Toxicological Methods|June 22, 2011
Safety pharmacology in 2010 and beyond: survey of significant events of the past 10 years and a roadmap to the immediate-, intermediate- and long-term future in recognition of the tenth anniversary of the Safety Pharmacology SocietyAlan S Bass, Hugo M Vargas, Jean-Pierre Valentin, et al.
Toxicology|November 20, 2012
Renal biomarker changes associated with hyaline droplet nephropathy in rats are time and potentially compound dependentDavid A Brott, Patricia Bentley, Murali V P Nadella, et al.
Basic & Clinical Pharmacology & Toxicology|June 30, 2012
Inhibition of oestradiol-induced prolactin release in a dual-cannulated ovariectomized rat model by carmoxirole, a peripherally restricted dopamine agonistDavid A Brott, Jennifer L Werkheiser, Pam Campbell, et al.
Environmental Toxicology and Chemistry|September 14, 2010
The value of repeating studies and multiple controls: replicated 28-day growth studies of rainbow trout exposed to clofibric acidStewart F Owen, Duane B Huggett, Thomas H Hutchinson, et al.
Pageof 3